Reported about 1 month ago
In response to recent market fluctuations, Amplify ETFs CEO Christian Magoon shares insights on ETFs that can provide stability. He recommends re-evaluating core equity positions and considering high-quality covered call strategies to generate income while mitigating risks. Additionally, he highlights the Amplify Weight Loss Drug and Treatment ETF (THNR), the first of its kind, which focuses on companies involved in the growing GLP-1 weight loss drug market. Magoon's advice aims to help investors navigate the unpredictable landscape of the stock market.
Source: YAHOO